These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Semaphorin-induced cytoskeletal collapse and repulsion of endothelial cells. Bielenberg DR, Shimizu A, Klagsbrun M. Methods Enzymol; 2008; 443():299-314. PubMed ID: 18772022 [Abstract] [Full Text] [Related]
6. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma. Kawakami T, Tokunaga T, Hatanaka H, Kijima H, Yamazaki H, Abe Y, Osamura Y, Inoue H, Ueyama Y, Nakamura M. Cancer; 2002 Nov 15; 95(10):2196-201. PubMed ID: 12412174 [Abstract] [Full Text] [Related]
7. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs. Margulis A, Zhang W, Alt-Holland A, Crawford HC, Fusenig NE, Garlick JA. Cancer Res; 2005 Mar 01; 65(5):1783-91. PubMed ID: 15753375 [Abstract] [Full Text] [Related]
8. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. Gray MJ, Van Buren G, Dallas NA, Xia L, Wang X, Yang AD, Somcio RJ, Lin YG, Lim S, Fan F, Mangala LS, Arumugam T, Logsdon CD, Lopez-Berestein G, Sood AK, Ellis LM. J Natl Cancer Inst; 2008 Jan 16; 100(2):109-20. PubMed ID: 18182619 [Abstract] [Full Text] [Related]
9. Neuropilin2 expressed in gastric cancer endothelial cells increases the proliferation and migration of endothelial cells in response to VEGF. Kim WH, Lee SH, Jung MH, Seo JH, Kim J, Kim MA, Lee YM. Exp Cell Res; 2009 Aug 01; 315(13):2154-64. PubMed ID: 19409892 [Abstract] [Full Text] [Related]
13. Prognostic significance of VEGF-C, semaphorin 3F, and neuropilin-2 expression in oral squamous cell carcinomas and their relationship with lymphangiogenesis. Zhang B, Gao Z, Sun M, Li H, Fan H, Chen D, Zheng J. J Surg Oncol; 2015 Mar 15; 111(4):382-8. PubMed ID: 25475162 [Abstract] [Full Text] [Related]
14. Site-directed mutagenesis in the B-neuropilin-2 domain selectively enhances its affinity to VEGF165, but not to semaphorin 3F. Geretti E, Shimizu A, Kurschat P, Klagsbrun M. J Biol Chem; 2007 Aug 31; 282(35):25698-707. PubMed ID: 17595163 [Abstract] [Full Text] [Related]
16. Semaphorin3F down-regulates the expression of integrin alpha(v)beta3 and sensitizes multicellular tumor spheroids to chemotherapy via the neuropilin-2 receptor in vitro. Zheng C, Zhou Q, Wu F, Peng Q, Tang A, Liang H, Zeng Y. Chemotherapy; 2009 Aug 31; 55(5):344-52. PubMed ID: 19657188 [Abstract] [Full Text] [Related]
19. The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma. Moragas N, Fernandez-Nogueira P, Recalde-Percaz L, Inman JL, López-Plana A, Bergholtz H, Noguera-Castells A, Del Burgo PJ, Chen X, Sorlie T, Gascón P, Bragado P, Bissell M, Carbó N, Fuster G. Breast Cancer Res; 2024 Aug 13; 26(1):122. PubMed ID: 39138514 [Abstract] [Full Text] [Related]